Catalog

Vishala Neppalli - Diagnostic Pathways in Lymphoproliferative Disorders Virtual Event - 07/12/2022 12pm (ET)
Online
Added:

FREE FOR MEMBERS!
Description: The session briefly covers the clinical relevance of current pathologic classifications in lymphoma. Choice and performance of ancillary laboratory testing platforms and results, with a focus on diagnostic yield.
Date: December 7, 2022
Time: 12pm – 1pm (ET)
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

About this item

FREE FOR MEMBERS!

Description: The session briefly covers the clinical relevance of current pathologic classifications in lymphoma. Choice and performance of ancillary laboratory testing platforms and results, with a focus on diagnostic yield.

Date: December 7, 2022

Time: 12pm – 1pm (ET)

Course/Activity Information

At the end of this session you will understand the:

  • Importance of specimen handling and processing
  • Impact of pre-analytical and post-analytical aspects influencing lymphoma diagnosis
  • Complexity of classification and clinical significance

 

Speaker: Vishala Neppalli, MD

Dr. Neppalli is a hematopathologist with an advanced expertise in lymphoid disorders. She is a US trained specialist, and practiced as an academic pathologist at University of Iowa Hospitals and Clinics, and at Roswell Park Comprehensive Cancer Centre (RPCCC, Buffalo, NY), prior to moving to Winnipeg. At RPCCC, Dr. Napalli was the Chief of Division of Diagnostic Hematology, where she was instrumental in developing an integrated hematopathology diagnostic reporting model. She has served as a panel member on Myeloma, Chronic lymphocytic leukemia/Hairy cell leukemia/Waldenstrom macroglobulinemia National Comprehensive Cancer Network (NCCN) guidelines.

 

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.

Close
Shopping Cart
Total:  Close

Loading Shopping Cart Items...